Valuation: DexCom, Inc.

Market Cap 33.79B 29.65B 27.87B 25.48B 47.62B 3,236B 47.97B 335B 130B 1,650B 127B 124B 5,350B P/E 2026 *
35.9x
P/E 2027 * 30.2x
Enterprise Value 33.02B 28.99B 27.25B 24.91B 46.55B 3,163B 46.89B 327B 127B 1,613B 124B 121B 5,229B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 5.64x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-1.22%
1 week+1.32%
Current month-2.82%
1 month-2.82%
3 months+28.40%
6 months+34.20%
Current year+33.33%
1 week 87.17
Extreme 87.17
90.38
1 month 82.29
Extreme 82.29
92.59
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Date Insider Type Main position Quantity % Market Cap. Importance
15/09/26 Sell

Compliance Officer

-1,700 0.0005%
15/09/26 Sell

Director

-6,539 0.0017%
10/09/26 Free

Director

5,841 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%+1.32%+29.75%+2.82% 33.79B
+0.34%+1.69%-23.40%+6.79% 179B
-0.77%-2.64%-5.06%+12.74% 116B
+0.11%-1.19%+4.07%+68.09% 60B
+0.15%+0.66%-1.86%-31.38% 49.85B
-0.22%+1.23%+7.80%+45.79% 48.05B
-0.46%+3.79% - - 30.21B
+0.46%+2.88%+48.50%-0.84% 26.12B
-0.39%+6.03%+9.83%-9.35% 22.98B
-2.33%-0.20%-8.89%+8.91% 20.98B
Average -0.47%+1.47%+6.75%+11.51% 58.75B
Weighted average by Cap. -0.25%+0.41%-3.50%+13.39%

Financials

2026 *2027 *
Net sales 5.23B 4.59B 4.32B 3.95B 7.37B 501B 7.43B 51.83B 20.09B 255B 19.64B 19.21B 828B 5.8B 5.09B 4.79B 4.37B 8.18B 556B 8.24B 57.48B 22.28B 283B 21.78B 21.3B 918B
Net income 974M 855M 804M 735M 1.37B 93.33B 1.38B 9.66B 3.74B 47.59B 3.66B 3.58B 154B 1.15B 1.01B 948M 867M 1.62B 110B 1.63B 11.39B 4.41B 56.11B 4.31B 4.22B 182B
Net Debt -761M -668M -628M -574M -1.07B -72.91B -1.08B -7.54B -2.92B -37.17B -2.86B -2.8B -121B -1.06B -932M -876M -801M -1.5B -102B -1.51B -10.52B -4.08B -51.84B -3.99B -3.9B -168B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
23/09/26 US$88.53 -1.12% 580,700
22/09/26 US$89.53 +0.40% 7,296,092
21/09/26 US$89.17 -0.20% 3,515,967
18/09/26 US$89.35 +1.61% 14,576,638
17/09/26 US$87.93 +0.68% 2,823,993
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.53USD
Average target price
94.48USD
Spread / Average Target
+5.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!